Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
07/2012
07/12/2012US20120177661 Human diacylglycerol acyltransferase 2 (dgat2) family members and uses therefor
07/12/2012US20120177660 Biomarkers and therapeutic targets for type 1 diabetes
07/12/2012US20120177659 Methods and compositions for treating and diagnosing diseases
07/12/2012US20120177656 Compounds and Methods for the Modulation of Sulfilimine Bond Formation
07/12/2012US20120177654 Method of treatment and agents useful for same
07/12/2012US20120177647 Mdl-1 uses
07/12/2012US20120177644 Mesenchymal stem cell differentiation
07/12/2012US20120177634 Demethylpenclomedine analogs and their use as anti-cancer agents
07/12/2012US20120177633 Methods for accelerating the healing of connective tissue injuries and disorders
07/12/2012US20120177630 Treatment of rett syndrome and other disorders
07/12/2012US20120177629 Predigested Nutritional Formula
07/12/2012US20120177628 Arginase formulations and methods
07/12/2012US20120177627 Upregulation of integrin linked kinase (ilk) to provide cardioprotective effects
07/12/2012US20120177626 Hdl comprising a therapeutic agent and use in therapy
07/12/2012US20120177625 Chemically modified factor ix
07/12/2012US20120177624 Oral disinfectant, and food additive comprising the disinfectant
07/12/2012US20120177610 Manufacturing and Purification Processes of Complex Protein found in Fraction IV to make a separated Apo, Transferrin , and Alpha 1 Anti strepsin (A1AT) or A combined Transferrin / Apo/Human Albumin/A1AT and all new found proteins
07/12/2012US20120177604 Formation of hydrogel in the presence of peroxidase and low concentration of hydrogen peroxide
07/12/2012US20120177603 Method for the purification of interferon-b
07/12/2012US20120177602 Dissolution aids for oral peptide delivery comprising a biguanide
07/12/2012US20120177601 Treatment of hepatitis c virus infections
07/12/2012US20120177600 Compositions and Methods for Inducing or Enhancing Connective Tissue Repair
07/12/2012US20120177599 Compositions and methods for treatment, diagnosis and prognonis of mesothelioma
07/12/2012US20120177598 Compositions and Methods for Immunomodulation in an Organism
07/12/2012US20120177597 Compositions and methods of alteration of autoimmune diseases
07/12/2012US20120177596 METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES
07/12/2012US20120177580 Metal Abstraction Peptide (MAP) Tag and Associated Methods
07/12/2012US20120177579 Metal Abstraction Peptide (MAP) Tag and Associated Methods
07/12/2012US20120177566 Membrane resident peptide in anti-cancer peptides causes tumor cell necrosis rather than apoptosis of cancer cells
07/12/2012CA2826086A1 Process for preparation of caspofungin acetate and intermediates
07/12/2012CA2823628A1 Spray drying vancomycin
07/12/2012CA2823491A1 Plasminogen and plasmin variants
07/11/2012EP2474558A1 New antibiotic containing simulacrum antibody, preparation method and application thereof
07/11/2012EP2474555A1 Wnt10-derived peptide and use thereof
07/11/2012EP2474325A1 Drug composition for angiogenesis therapy
07/11/2012EP2474321A1 Compositions suitable for treating collagen-mediated diseases
07/11/2012EP2474320A1 Compositions suitable for treating collagen-mediated diseases
07/11/2012EP2474319A1 Compositions suitable for treating collagen-mediated diseases
07/11/2012EP2474318A1 Albumin fusion proteins
07/11/2012EP2474317A1 Treatment of conditions involving demyelination
07/11/2012EP2474316A1 Analogs of SHK toxin and their uses in selective inhibition of KV1.3 potassium channels
07/11/2012EP2474315A1 Immunity inducer
07/11/2012EP2474311A2 Method for treating th17 inflammatory disease through inhibition of vascular endothelial growth factor receptors and pharmaceutical composition therefor
07/11/2012EP2474306A1 Particle composition and medicinal composition comprising same
07/11/2012EP2473850A1 Compositions and methods for treating growth hormone deficiency
07/11/2012EP2473637A1 Methods for treating, diagnosing, and monitoring rheumatoid arthritis
07/11/2012EP2473523A2 Methods and compositions for the inhibition of transplant rejection
07/11/2012EP2473521A2 B7-h4 fusion proteins and methods of use thereof
07/11/2012EP2473518A2 Stabilized melanocortin ligands
07/11/2012EP2473517A1 Transglutaminase-activating peptide, and cosmetic or pharmaceutical composition containing same
07/11/2012EP2473516A1 Antibiotic compounds
07/11/2012EP2473196A2 Sdf-1 delivery for treating ischemic tissue
07/11/2012EP2473194A1 Stable formulation of factor viii
07/11/2012EP2473185A1 Treatment of neurological or neurodegenerative disorders
07/11/2012EP2473184A1 Modified agrin-fragment capable of restoring muscle strength for use as a medicament
07/11/2012EP2473183A2 Cosmetic uses of modified stressed yeast extracts and related compositions
07/11/2012EP2473182A2 Targeted delivery using tissue-specific peptidomimetic ligands
07/11/2012EP2473181A1 Antithrombotic compounds
07/11/2012EP2473159A2 A composition for delaying cellular senescence
07/11/2012EP2473039A1 Durable treatment with 4-aminopyridine in patients with demyelination
07/11/2012EP2293785B1 Nanoparticles containing a peptide, vectors containing the same and pharmaceutical uses of said nanoparticles and said vectors
07/11/2012EP2285349B1 Perfluorcarbon nanoemulsions with endocytosis enhancing surface for gene-transfer
07/11/2012EP2187913B1 Ac-RFMWMR-NH2 for use in the treatment of Mycobacterium tuberculosis related diseases
07/11/2012EP2164507B1 Treatment of allergic disease with immunomodulator compounds
07/11/2012EP2034015B1 Immunostimulatory oligonucleotide and pharmaceutical application thereof
07/11/2012EP2023950B1 Urodilatin cancer treatment
07/11/2012EP1855705B1 Antibiotic 107891, its factors, pharmaceutically acceptable salts and compositions, and use thereof
07/11/2012EP1766768B1 Use of lacritin in promoting ocular cell survival
07/11/2012EP1762242B1 MALIGNANT TUMOR INHIBITOR CONTAINING Des A FIBRIN
07/11/2012EP1745065B1 Antimicrobial polypeptides
07/11/2012EP1732609B1 Conjugates of hydroxyalkyl starch and a protein
07/11/2012EP1731160B1 Cancer metastasis inhibitory composition
07/11/2012EP1636335B1 Compositions and methods for inhibiting an isoform of human manganese superoxide dismutase
07/11/2012EP1513544B1 Retrocyclins: antiviral and antimicrobial peptides
07/11/2012EP1453966B1 Method for producing a recombinant polypeptide
07/11/2012EP1300416B1 Memory-enhancing peptides and the use thereof
07/11/2012EP1259547B1 High potency recombinant antibodies and method for producing them
07/11/2012EP1169456B1 Recombinant production of Clostridium difficile Toxin A or Toxin B
07/11/2012CN1966520B Peptides and compounds that bind to a receptor
07/11/2012CN1934255B Combination therapy for the treatment of ocular neovascular disorders
07/11/2012CN1762381B Ophthalmic compositions containing galactomannan polymers and borate
07/11/2012CN102575240A New endolysin oBPgpLYS
07/11/2012CN102575236A Inhibition of histone acetyltransferases by CTK7A and methods thereof
07/11/2012CN102574908A Targeting tissue factor to activated platelets
07/11/2012CN102574904A Motilin-like peptide compound having transmucosal absorbability imparted thereto
07/11/2012CN102574903A Acylated glucagon analogues
07/11/2012CN102574902A Serum amyloid P derivatives and their preparation and use
07/11/2012CN102574901A Novel haemoglobin and uses thereof
07/11/2012CN102574894A Stabilized melanocortin ligands
07/11/2012CN102574892A Antibiotic compounds
07/11/2012CN102573924A Drug composition for angiogenesis therapy
07/11/2012CN102573892A Use of GSTP1
07/11/2012CN102573891A Polymer particles and uses thereof
07/11/2012CN102573890A Modified factor ix polypeptides and uses thereof
07/11/2012CN102573888A Long-acting Y2 receptor agonists
07/11/2012CN102573887A Osteolysis treatment
07/11/2012CN102573886A Method of treating asthma with antiviral agents
07/11/2012CN102573885A Composition having lipolysis-promoting effect
07/11/2012CN102573884A Novel peptides isolated from spider venom, and uses thereof
07/11/2012CN102573883A Methods and compositions for promoting a cell-mediated immune response
1 ... 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 ... 3163